Unknown

Dataset Information

0

Pyridylbenzimidazole based Re(i)(CO)3 complexes: antimicrobial activity, spectroscopic and density functional theory calculations.


ABSTRACT: fac-[ReBr(CO)3(L1,2)] L1 = 1-ethyl-2-(pyridin-2-yl)benzimidazole (1) and L2 = 1-[(pyridin-2-yl) benzimidazole]-propyl-sulfonic acid (2), fac-[Re2Br2(CO)6L3] (3) L3 = 1,1'-(hexane-1,6-diyl)bis[2-(pyridin-2-yl)1H-benzimidazole] and fac-[ReBr(CO)3(L4,52N1N2)] (L4 = 2,6-bis(benzimidazol-2'-yl)pyridine (4) and L5 = 2,6-bis(1-ethyl-benzimidazol-2'-yl)pyridine (5) were synthesized and fully characterized using different spectrocopic and analytical tools. The spectrocopic data showed coordination of L1-3 to fac-ReBr(CO)3 via the benzimidazole and pyridine N-atoms. For 4 and 5, the absence of a two-fold axis of symmetry for L4,5 in the 1H NMR spectra reflect the κ2N1,N2 mode of coordination. The electronic properties of 1-5 were investigated by time-dependent density functional theory calculations in the singlet and triplet states. The ligands and their Re(i) complexes were assessed for their potential antimicrobial activity. Compound 5 was screened against non-malignant cell line (noncancerous human embryonic kidney cell line (HEK293)) as well as evaluated for its blood compatibility.

SUBMITTER: Mansour AM 

PROVIDER: S-EPMC9064247 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pyridylbenzimidazole based Re(i)(CO)<sub>3</sub> complexes: antimicrobial activity, spectroscopic and density functional theory calculations.

Mansour Ahmed M AM  

RSC advances 20190514 26


<i>fac</i>-[ReBr(CO)<sub>3</sub>(L<sup>1,2</sup>)] L<sup>1</sup> = 1-ethyl-2-(pyridin-2-yl)benzimidazole (1) and L<sup>2</sup> = 1-[(pyridin-2-yl) benzimidazole]-propyl-sulfonic acid (2), <i>fac</i>-[Re<sub>2</sub>Br<sub>2</sub>(CO)<sub>6</sub>L<sup>3</sup>] (3) L<sup>3</sup> = 1,1'-(hexane-1,6-diyl)bis[2-(pyridin-2-yl)1<i>H</i>-benzimidazole] and <i>fac</i>-[ReBr(CO)<sub>3</sub>(L<sup>4,5</sup>-κ<sup>2</sup>N<sup>1</sup>N<sup>2</sup>)] (L<sup>4</sup> = 2,6-bis(benzimidazol-2'-yl)pyridine (4) an  ...[more]

Similar Datasets

| S-EPMC5539101 | biostudies-other
| S-EPMC5115656 | biostudies-literature
| S-EPMC4848975 | biostudies-literature
| S-EPMC9979613 | biostudies-literature
| S-EPMC10856687 | biostudies-literature
| S-EPMC8753653 | biostudies-literature
| S-EPMC10707806 | biostudies-literature
| S-EPMC2777692 | biostudies-literature
| S-EPMC9575150 | biostudies-literature
| S-EPMC9631882 | biostudies-literature